Robby D. Bowles

1.1k total citations
27 papers, 891 citations indexed

About

Robby D. Bowles is a scholar working on Pathology and Forensic Medicine, Pharmacology and Physiology. According to data from OpenAlex, Robby D. Bowles has authored 27 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 9 papers in Pharmacology and 7 papers in Physiology. Recurrent topics in Robby D. Bowles's work include Spine and Intervertebral Disc Pathology (15 papers), Musculoskeletal pain and rehabilitation (7 papers) and Pain Mechanisms and Treatments (5 papers). Robby D. Bowles is often cited by papers focused on Spine and Intervertebral Disc Pathology (15 papers), Musculoskeletal pain and rehabilitation (7 papers) and Pain Mechanisms and Treatments (5 papers). Robby D. Bowles collaborates with scholars based in United States, France and Singapore. Robby D. Bowles's co-authors include Lawrence J. Bonassar, Harry Gebhard, Roger Härtl, Niloofar Farhang, Brandon D. Lawrence, Lori A. Setton, Rebecca M. Williams, Warren R. Zipfel, Jason Gertz and Farshid Guilak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biomaterials and Carbohydrate Polymers.

In The Last Decade

Robby D. Bowles

27 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robby D. Bowles United States 15 467 339 326 183 156 27 891
Isma Liza Mohd Isa Ireland 13 463 1.0× 363 1.1× 237 0.7× 203 1.1× 154 1.0× 25 892
Hongxing Shen China 16 447 1.0× 242 0.7× 196 0.6× 138 0.8× 167 1.1× 22 749
Xiexing Wu China 17 291 0.6× 189 0.6× 246 0.8× 198 1.1× 312 2.0× 34 901
Jingguo Xin China 7 457 1.0× 315 0.9× 165 0.5× 162 0.9× 179 1.1× 10 789
Ruiqiang Chen China 17 434 0.9× 196 0.6× 383 1.2× 121 0.7× 235 1.5× 47 968
Roel J. W. Hoogendoorn Netherlands 13 875 1.9× 637 1.9× 408 1.3× 213 1.2× 136 0.9× 15 1.1k
Sunren Sheng China 18 407 0.9× 171 0.5× 286 0.9× 160 0.9× 263 1.7× 36 905
Kan Xu China 17 268 0.6× 70 0.2× 332 1.0× 251 1.4× 213 1.4× 38 1.0k
Kevin Ngo United States 13 432 0.9× 317 0.9× 167 0.5× 94 0.5× 139 0.9× 20 661
Haibin Xu China 12 273 0.6× 139 0.4× 143 0.4× 96 0.5× 189 1.2× 30 629

Countries citing papers authored by Robby D. Bowles

Since Specialization
Citations

This map shows the geographic impact of Robby D. Bowles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robby D. Bowles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robby D. Bowles more than expected).

Fields of papers citing papers by Robby D. Bowles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robby D. Bowles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robby D. Bowles. The network helps show where Robby D. Bowles may publish in the future.

Co-authorship network of co-authors of Robby D. Bowles

This figure shows the co-authorship network connecting the top 25 collaborators of Robby D. Bowles. A scholar is included among the top collaborators of Robby D. Bowles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robby D. Bowles. Robby D. Bowles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zitnay, Jared L., et al.. (2024). Toward the Development of a Tissue Engineered Gradient Utilizing CRISPR-Guided Gene Modulation. Tissue Engineering Part A. 30(17-18). 525–535. 2 indexed citations
3.
Farhang, Niloofar, et al.. (2024). Therapeutic CRISPR epigenome editing of inflammatory receptors in the intervertebral disc. Molecular Therapy. 32(11). 3955–3973. 5 indexed citations
6.
Farhang, Niloofar, et al.. (2020). Improving Cell Therapy Survival and Anabolism in Harsh Musculoskeletal Disease Environments. Tissue Engineering Part B Reviews. 26(4). 348–366. 12 indexed citations
7.
Farhang, Niloofar, et al.. (2020). Synergistic CRISPRa-Regulated Chondrogenic Extracellular Matrix Deposition Without Exogenous Growth Factors. Tissue Engineering Part A. 26(21-22). 1169–1179. 22 indexed citations
8.
Farhang, Niloofar, et al.. (2019). Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration. Human Gene Therapy. 30(9). 1161–1175. 53 indexed citations
10.
Farhang, Niloofar, et al.. (2018). Microfluidic Flow Cell Array for Controlled Cell Deposition in Engineered Musculoskeletal Tissues. Tissue Engineering Part C Methods. 24(9). 546–556. 8 indexed citations
11.
Farhang, Niloofar, Jonathan M. Brunger, Pratiksha I. Thakore, et al.. (2017). CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments. Tissue Engineering Part A. 23(15-16). 738–749. 72 indexed citations
12.
Farhang, Niloofar, et al.. (2017). CRISPR Epigenome Editing of AKAP150 in DRG Neurons Abolishes Degenerative IVD-Induced Neuronal Activation. Molecular Therapy. 25(9). 2014–2027. 39 indexed citations
13.
Farhang, Niloofar, et al.. (2015). Use of CRISPR genome-editing technology to promote osteogenic differentiation in human adipose-derived mesenchymal stem cells (hAD-MSCs). Undergraduate Research Journal. 2 indexed citations
14.
Bowles, Robby D., Jonathan M. Brunger, David M. Tainter, et al.. (2013). Injectable laminin-functionalized hydrogel for nucleus pulposus regeneration. Biomaterials. 34(30). 7381–7388. 89 indexed citations
15.
Bowles, Robby D., et al.. (2013). In Vivo Luminescence Imaging of NF‐κB Activity and Serum Cytokine Levels Predict Pain Sensitivities in a Rodent Model of Osteoarthritis. Arthritis & Rheumatology. 66(3). 637–646. 50 indexed citations
16.
Gebhard, Harry, Andrew James, Robby D. Bowles, et al.. (2011). Biological intervertebral disc replacement: an in vivo model and comparison of two surgical techniques to approach the rat caudal disc. PubMed. 2(1). 29–35. 9 indexed citations
17.
Bowles, Robby D., Harry Gebhard, Jonathan P. Dyke, et al.. (2011). Image‐based tissue engineering of a total intervertebral disc implant for restoration of function to the rat lumbar spine. NMR in Biomedicine. 25(3). 443–451. 40 indexed citations
18.
Bowles, Robby D., Harry Gebhard, Roger Härtl, & Lawrence J. Bonassar. (2011). Tissue-engineered intervertebral discs produce new matrix, maintain disc height, and restore biomechanical function to the rodent spine. Proceedings of the National Academy of Sciences. 108(32). 13106–13111. 156 indexed citations
19.
Gebhard, Harry, et al.. (2010). Total disc replacement using a tissue-engineered intervertebral disc in vivo: new animal model and initial results. PubMed. 1(2). 62–66. 23 indexed citations
20.
Bowles, Robby D., Rebecca M. Williams, Warren R. Zipfel, & Lawrence J. Bonassar. (2009). Self-Assembly of Aligned Tissue-Engineered Annulus Fibrosus and Intervertebral Disc Composite Via Collagen Gel Contraction. Tissue Engineering Part A. 16(4). 1339–1348. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026